missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Sitravatinib, MedChemExpress
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
200 mg
Unit Size:
100mg
10mg
200mg
50mg
5mg
Description
Sitravatinib (MGCD516) is an orally bioavailable receptor tyrosine kinase (RTK) inhibitor with IC50s of 1.5 nM, 2 nM, 2 nM, 5 nM, 6 nM, 6 nM, 8 nM, 0.5 nM, 29 nM, 5 nM, and 9 nM for Axl, MER, VEGFR3, VEGFR2, VEGFR1, KIT, FLT3, DDR2, DDR1, TRKA, TRKB, respectively. Sitravatinib shows potent single-agent antitumor efficacy and enhances the activity of PD-1 blockade through promoting an antitumor immune microenvironment.
Specifications
Specifications
| Chemical Name or Material | Sitravatinib |
| CAS | 1123837-84-2 |
| Color | Off-White |
| Purity Grade Notes | Research |
| Molecular Formula | C33H29F2N5O4S |
| Quantity | 5 mg |
| Synonym | MGCD516 MG-516 |
| Solubility Information | DMSO : ≥ 32 mg/mL (50.82 mM) |
| SMILES | O=C(C1(C(NC2=CC=C(F)C=C2)=O)CC1)NC3=CC=C(OC4=C5C(C=C(C6=NC=C(CNCCOC)C=C6)S5)=NC=C4)C(F)=C3 |
| Molecular Weight (g/mol) | 629.68 |
| Show More |
Research purposes only
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction